Rare Diseases: CBER Looks To ‘Lean Into’ Accelerated Approval, Align More With CDER

 
• By Sue Sutter
  
Walking in step
FDA's Peter Marks believes CBER and CDER will be walking in step more often going forward. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards